Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy

Blood Adv. 2024 Apr 23;8(8):1959-1963. doi: 10.1182/bloodadvances.2023011168.
No abstract available

MeSH terms

  • Antigens, CD19 / immunology
  • B-Lymphocytes* / immunology
  • B-Lymphocytes* / metabolism
  • Immunotherapy, Adoptive* / adverse effects
  • Receptors, Antigen, T-Cell*
  • Receptors, Chimeric Antigen / immunology
  • T-Lymphocytes

Substances

  • Receptors, Antigen, T-Cell
  • Antigens, CD19
  • Receptors, Chimeric Antigen